TRML (Tourmaline Bio) Buyback Yield % : 0.00 (As of Jul. 11, 2025)

View and export this data going back to 2023. Start your Free Trial

What is Tourmaline Bio Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Tourmaline Bio's current buyback yield was 0.00%.

Tourmaline Bio Buyback Yield % Historical Data

The historical data trend for Tourmaline Bio's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tourmaline Bio Buyback Yield % Chart

Tourmaline Bio Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

-13.23

-31.06

Tourmaline Bio Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buyback Yield %	Get a 7-Day Free Trial							-27.47	-48.92	-24.47	-31.06	-

Competitive Comparison of Tourmaline Bio's Buyback Yield %

For the Biotechnology subindustry, Tourmaline Bio's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tourmaline Bio's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tourmaline Bio's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Tourmaline Bio's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Tourmaline Bio Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Tourmaline Bio's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	161.352)	/	519.53304
	=	-31.06%

Tourmaline Bio's annualized Buyback Yield for the quarter that ended in Mar. 2025 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	0)		/	390.65364
	=	0.00%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Tourmaline Bio Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Tourmaline Bio's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tourmaline Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tourmaline Bio Inc (NAS:TRML) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

27 West 24th Street, Suite 702, New York, NY, USA, 10010

Website

https://www.tourmalinebio.com

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.